Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYBR CyberCare the new look of healthcare -- Ignore unavailable to you. Want to Upgrade?

To: Sir Auric Goldfinger who wrote (220)	2/26/2000 8:23:00 PM
From: Patrick Lauder	Read Replies (1) \| Respond to of 3392

Auric, What are you saying,.... that CYBR is not that important to ING Barings as we would like to think? So What! That Conn issued a Strong Buy Recommendation which would possibly benefit CYBR which would pay less interest on the debentures? So What! How does that affect the companies product that has been tested by the DOD and Mayo and now Iowa, and is being ordered in the US and China, and that could change the way the world does medicine in the future. How does what you state change all that??? Pat